-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Tcr2 Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to 2022.
- Tcr2 Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$40M, a 28.5% decline year-over-year.
- Tcr2 Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$101M, a 24.3% decline from 2021.
- Tcr2 Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$81.6M, a 43.8% decline from 2020.
- Tcr2 Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$56.7M, a 37.2% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)